PACTR202402529220760尚未招募3 期
A Pragmatic Phase III Multi-Centre Clinical Trial to Evaluate the Safety and Effectiveness of a Single Dose of an Albendazole-Ivermectin Coformulation vs Albendazole for Preventive Chemotherapy of Soil-Transmitted Helminth Infections in School-Aged Children
aboratorios Liconsa SA0 个研究点目标入组 20,000 人开始时间: 2024年2月5日最近更新:
适应症
试验速览
- 阶段
- 3 期
- 状态
- 尚未招募
- 发起方
- 入组人数
- 20,000
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 2 Year(s) 至 5 Year(s)（—）
- 性别
- All
入选标准
- •Age: 5 to 17 years old (included).
- •- Height: over 90cm.
- •- Parental acceptance to participate in the study by obtaining written informed consent approved by the Ethics Committee. Written assent will also be obtained from children according to the local national legislation. (In Kenya written assent will be obtained from children 12-17 years old and in Ghana for children 15-17 years old.)
排除标准
- •- Epidemiological risk of being infected by Loa loa.
- •- Serious medical illness, per investigator’s criteria.
- •- Any condition prevents the appropriate evaluation and follow-up of the participant, per the investigator’s criteria.
- •- Known hypersensitivity to any component of either study treatment.
- •- Pregnant or first week post-partum, reported by the participant during interview.
研究者
相似试验
进行中（未招募）
1 期
Phase 2/3 Clinical Trial with Sodium Thiosulfate for the Treatment of CalciphylaxisCalciphylaxisMedDRA version: 20.0Level: PTClassification code 10051714Term: CalciphylaxisSystem Organ Class: 10027433 - Metabolism and nutrition disordersEUCTR2014-002128-28-ATDr. F. Köhler Chemie GmbH40
进行中（未招募）
1 期
Phase 2/3 Clinical Trial with Sodium Thiosulfate for the Treatment of CalciphylaxisCalciphylaxisMedDRA version: 20.0Level: PTClassification code 10051714Term: CalciphylaxisSystem Organ Class: 10027433 - Metabolism and nutrition disordersEUCTR2014-002128-28-DEDr. F. Köhler Chemie GmbH40
已完成
2 期
A clinical trial with Sodium Thiosulfate for the treatment of CalciphylaxisCalciphylaxisCirculatory SystemISRCTN73380053Dr. F. Köhler Chemie GmbH (Germany)5
进行中（未招募）
1 期
Prospective multicenter phase III clinical trial using cytoreductive surgery with hyperthermic intraoperative chemotherapy (HIPEC) after preoperative chemotherapy in patients with peritoneal carcinomatosis of gastric cancer incl. adenocarcinoma of the esophagogastreal junctioPeritoneal carcinomatosis of gastric cancer incl. adenocarcinoma of the esophagogastreal junctionMedDRA version: 20.0Level: LLTClassification code 10042080Term: Stomach cancerSystem Organ Class: 100000004864MedDRA version: 20.0Level: LLTClassification code 10042081Term: Stomach cancer in situSystem Organ Class: 100000004864EUCTR2006-006088-22-DEKlinik für Chirurgie, Charité Campus Virchow-Klinikum180
已完成
3 期
Prospective multicenter phase III clinical trial using cytoreductive surgery with hyperthermic intraoperative chemotherapy (HIPEC)after preoperative chemotherapy in patients with peritoneal carcinomatosis of gastric cancer incl. adenocarcinoma of the esophagogastreal junctioMedDRA - 10042080 (stomach cancer)C16D00.2C78.6C79Malignant neoplasm of stomachStomachSecondary malignant neoplasm of retroperitoneum and peritoneumSecondary malignant neoplasm of other and unspecified sitesDRKS00003078Charité Campus Charité Mitte105